Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes.
BACKGROUND
Mutant HIV (HIV-Env-Tr712) lacking the cytoplasmic tail of the viral glycoprotein (Env-CT) exhibits a cell-type specific replication phenotype such that replicative spread occurs in some T-cell lines (referred to as permissive cells) but fails to do so in most T-cell lines or in PBMCs (referred to as non-permissive cells). We aim to gain insight on the underlying requirement for the Env-CT for viral spread in non-permissive cells.


RESULTS
We established that in comparison to HIV-Wt, both cell-free and cell-to-cell transmission of mutant HIV-Env-Tr712 from non-permissive cells were severely impaired under naturally low infection conditions. This requirement for Env-CT could be largely overcome by using saturating amounts of virus for infection. We further observed that in permissive cells, which supported both routes of mutant virus transmission, viral gene expression levels, Gag processing and particle release were inherently higher than in non-permissive cells, a factor which may be significantly contributing to their permissivity phenotype. Additionally, and correlating with viral transfer efficiencies in these cell types, HIV-Gag accumulation at the virological synapse (VS) was reduced to background levels in the absence of the Env-CT in conjugates of non-permissive cells but not in permissive cells.


CONCLUSIONS
During natural infection conditions, the HIV-Env-CT is critically required for viral transmission in cultures of non-permissive cells by both cell-free and cell-to-cell routes and is instrumental for Gag accumulation to the VS. The requirement of the Env-CT for these related processes is abrogated in permissive cells, which exhibit higher HIV gene expression levels.
Emerson
Vanessa
V
Forschungsschwerpunkt Infektion und Krebs, F020, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Haller
Claudia
C
Pfeiffer
Tanya
T
Fackler
Oliver T
OT
Bosch
Valerie
V
D002460:Cell Line; D019302:HIV Envelope Protein gp160 / Q000235:genetics / Q000502:physiology*; D015497:HIV-1 / Q000254:growth & development / Q000472:pathogenicity*; D006801:Humans; D013601:T-Lymphocytes / Q000821:virology*; D037521:Virulence Factors / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication
D019302:HIV Envelope Protein gp160; D037521:Virulence Factors
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4
2191297
J Virol. 1994 Aug;68(8):4857-61
8035484
Science. 2009 Mar 27;323(5922):1743-7
19325119
AIDS Res Hum Retroviruses. 1994 Apr;10(4):371-81
8068416
Biol Chem. 2008 Oct;389(10):1253-60
18713012
J Virol. 2008 Aug;82(16):7773-89
18508887
AIDS Res Hum Retroviruses. 2006 Jan;22(1):57-65
16438647
J Virol. 1992 Nov;66(11):6616-25
1357190
J Virol. 2007 Jun;81(11):5547-60
17360745
J Virol. 2007 Nov;81(22):12582-95
17728240
Traffic. 2004 Sep;5(9):643-50
15296489
J Virol. 2007 Aug;81(15):7873-84
17522207
J Virol. 1992 Nov;66(11):6547-54
1404602
EMBO J. 2007 Jan 24;26(2):516-26
17215865
Science. 2003 Mar 14;299(5613):1713-6
12589003
Retrovirology. 2006 May 16;3:27
16700925
J Exp Med. 2004 Jan 19;199(2):283-93
14734528
Virology. 1998 Nov 10;251(1):16-21
9813198
Science. 1985 Mar 8;227(4691):1227-8
2983419
J Virol. 1996 Jan;70(1):341-51
8523546
J Virol. 2000 Apr;74(8):3548-54
10729129
J Virol. 2007 Dec;81(24):13916-21
17913807
AIDS Res Hum Retroviruses. 2007 May;23(5):729-40
17531000
J Virol. 2000 Oct;74(20):9381-7
11000206
Virology. 1999 Dec 20;265(2):319-29
10600603
J Virol. 1990 May;64(5):2337-44
2182911
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):343-8
10618420
J Virol. 2004 Apr;78(7):3429-35
15016865
Science. 1996 Apr 12;272(5259):263-7
8602510
EMBO J. 1997 Feb 17;16(4):695-705
9049299
J Biol Chem. 2004 Dec 3;279(49):51305-14
15371410
PLoS Biol. 2009 Jul;7(7):e1000163
19636361
J Virol. 2004 Oct;78(19):10803-13
15367647
J Virol. 1995 Jun;69(6):3824-30
7745730
Virology. 1992 Jul;189(1):167-77
1604808
J Virol. 2010 Apr;84(7):3516-27
20089656
Nat Cell Biol. 2007 Mar;9(3):310-5
17293854
J Virol. 1993 Apr;67(4):2182-90
8445728
Nat Cell Biol. 2008 Feb;10(2):211-9
18193035
Virology. 1992 Feb;186(2):712-24
1370739
J Virol. 1999 Jun;73(6):5010-7
10233963
EMBO J. 1996 Nov 1;15(21):5783-8
8918455
J Virol. 2007 Jan;81(2):1000-12
17079292
J Virol. 2010 Feb;84(3):1355-65
19906925
Science. 1985 Aug 9;229(4713):563-6
2992081
J Virol. 2000 May;74(10):4891-3
10775630
J Virol. 1993 Jan;67(1):213-21
8416370
J Virol. 2009 Jun;83(12):6234-46
19369333